Basically, high TS expression has been shown to result in relatively low sensitivity to fluoropyrimidine-based chemotherapy, including S-1.29, 30 Downregulation of TMPRSS4 may sensitize cancer cells to the cytotoxic effects of S-1 via decreased expression of TS. This evidence concerns the gene TYMS and cancer.